...
首页> 外文期刊>Biochemistry >Sequence-Selective Recognition of Duplex DNA through Covalent Interstrand Cross-Linking: Kinetic and Molecular Modeling Studies with Pyrrolobenzodiazepine Dimers
【24h】

Sequence-Selective Recognition of Duplex DNA through Covalent Interstrand Cross-Linking: Kinetic and Molecular Modeling Studies with Pyrrolobenzodiazepine Dimers

机译:通过共价Interstrand交联对双链DNA进行序列选择性识别:用吡咯唑二氧己酮二聚体的动力学和分子建模研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Members of a homologous series of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers with C8-O-(CH_2)_n-O-C8' diether linkages (n=3-6 for 2a-d, respectively) have been studied for their ability to interact with oligonucleotide duplexes containing potential target binding sites. The results confirm earlier predictions that the n=3 analogue (2a, DSB-120) will covalently bind to a 5'-Pu-GATC-Py sequence by cross-linking opposite-strand guanines separated by 2 bp. Preference for this DNA sequence is shown using oligonucleotides with altered bases between and/or flanking these guanines. The more extended PBD dimer 2c (n=5) can span an extra base pair and cross-link the 5'-Pu-Ga(T/A)TC-Py sequence. The ability of each homologue to cross-link linear plasmid DNA has been determined, with a rank order that correlates with the reported order of in vitro cytotoxicity: n=3 (2a) > n=5 (2c) > n=6 (2d) > n=4(2b). The n=3 homologue (2a) is >300-fold more efficient at cross-linking DNA than the clinically used cross-linking agent melphalan under the same conditions. Kinetic studies reveal that the n=3 and 5 dimers achieve faster cross-linking to plasmid DNA (108 and 81% cross-linking h~(-1) muM~(-1) at 37 deg C, respectively), whereas the n=4 and 6 homologues are significantly less efficient at 10.3 and 23% cross-linking h~(-1) muM~(-1), respectively. Alternating activity for the odd n and even n dimers is probably due to cofigurational factors governed by the spatial separation of the PBD subunits and the flexible character of the tethering linkage. Molecular modeling confirms the order of cross-linking reactivity, and highlights the role of linker length in dictating sequence recognition for this class of DNA-reactive agent.
机译:具有C8-O-(CH_2)_N-O-C8'TETHER键(N = 3-6的PBZOIDIAZINE(PBD)二聚体的同源系列的吡咯并[2,1-C] [1,4]苯并二氮氧基(PBD)二聚体(n = 3-6用于2A-D.分别研究了它们与含有潜在靶结合位点的寡核苷酸双链体相互作用的能力。结果证实了N = 3类似物(2A,DSB-120)将通过交联与2BP分开的相对鸟脉共价结合到5'-PU-GATC-PY序列的预测。使用寡核苷酸的寡核苷酸显示该DNA序列的偏好,所述寡核苷酸与这些鸟嘌呤之间的碱基和/或侧翼之间的碱基。更扩展的PBD二聚体2c(n = 5)可以跨越额外的基对并交联5'-pu-ga(t / a)tc-py序列。已经确定了每个同源物到交联线性质粒DNA的能力,其等级顺序与报告的体外细胞毒性顺序相关:n = 3(2a)> n = 5(2℃)> n = 6(2d )> n = 4(2b)。在交联DNA时,n = 3同源物(2a)在相同条件下的交联DNA的交联DNA高效。动力学研究表明,n = 3和5二聚体可以在37℃,而n = 4和6种同源物在10.3和23%的交联H〜(-1)毫米〜(-1)中显着效率显着较低。奇数N和均匀N二聚体的交替活动可能是由于PBD亚基的空间分离和束缚连杆的柔性特征所致的封闭因素。分子建模证实交联反应性的顺序,并突出了接头长度在该类DNA反应性试剂对序列识别中的作用。

著录项

  • 来源
    《Biochemistry》 |2003年第27期|共8页
  • 作者单位

    Cancer Research UK Drug-DNA Interactions Research Group Department of Oncology Royal Free &

    University of College Medical School UCL 91 Riding House Street London W1W 7BS U.K. Cancer Research UK Gene Targeted Drug Design Research Group The Sc;

    Cancer Research UK Drug-DNA Interactions Research Group Department of Oncology Royal Free &

    University of College Medical School UCL 91 Riding House Street London W1W 7BS U.K. Cancer Research UK Gene Targeted Drug Design Research Group The Sc;

    Cancer Research UK Drug-DNA Interactions Research Group Department of Oncology Royal Free &

    University of College Medical School UCL 91 Riding House Street London W1W 7BS U.K. Cancer Research UK Gene Targeted Drug Design Research Group The Sc;

    Cancer Research UK Drug-DNA Interactions Research Group Department of Oncology Royal Free &

    University of College Medical School UCL 91 Riding House Street London W1W 7BS U.K. Cancer Research UK Gene Targeted Drug Design Research Group The Sc;

    Cancer Research UK Drug-DNA Interactions Research Group Department of Oncology Royal Free &

    University of College Medical School UCL 91 Riding House Street London W1W 7BS U.K. Cancer Research UK Gene Targeted Drug Design Research Group The Sc;

    Cancer Research UK Drug-DNA Interactions Research Group Department of Oncology Royal Free &

    University of College Medical School UCL 91 Riding House Street London W1W 7BS U.K. Cancer Research UK Gene Targeted Drug Design Research Group The Sc;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号